Daniel R. Chevallard insider trades: LENZ Therapeutics (LENZ) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | LENZ | ↑ Buy | 2,198 | $22.76 | $50K | Direct | Nov 7, 2025 (0d) |
| May 14, 2024 | LENZ | ↑ Buy | 3,188 | $15.68 | $50K | Direct | May 15, 2024 (1d) |
| Feb 27, 2024 | VIRX | ↓ Sell | 3,405 | $0.73 | $2K | Direct | Feb 27, 2024 (0d) |
| Nov 28, 2023 | VIRX | ↓ Sell | 3,720 | $0.50 | $2K | Direct | Nov 28, 2023 (0d) |
| Aug 28, 2023 | VIRX | ↓ Sell | 3,512 | $1.45 | $5K | Direct | Aug 29, 2023 (1d) |
| May 25, 2023 | VIRX | ↓ Sell | 3,635 | $1.42 | $5K | Direct | May 26, 2023 (1d) |
| Feb 27, 2023 | VIRX | ↓ Sell | 3,599 | $1.68 | $6K | Direct | Feb 28, 2023 (1d) |
| Nov 28, 2022 | VIRX | ↓ Sell | 3,532 | $2.72 | $10K | Direct | Nov 29, 2022 (1d) |
| Aug 26, 2022 | VIRX | ↓ Sell | 3,655 | $4.02 | $15K | Direct | Aug 29, 2022 (3d) |
| May 26, 2022 | VIRX | ↓ Sell | 3,596 | $1.90 | $7K | Direct | May 27, 2022 (1d) |
| Feb 28, 2022 | VIRX | ↓ Sell | 3,998 | $2.78 | $11K | Direct | Mar 1, 2022 (1d) |
| Nov 29, 2021 | VIRX | ↓ Sell | 7,579 | $4.81 | $36K | Direct | Nov 29, 2021 (0d) |
| Jul 1, 2019 | RGLS | ↓ Sell | 2,669 | $1.31 | $4K | Direct | Jul 2, 2019 (1d) |
| May 15, 2019 | RGLS | ↓ Sell | 10,000 | $1.41 | $14K | Direct | May 16, 2019 (1d) |
| Apr 1, 2019 | RGLS | ↓ Sell10b5-1 | 3,253 | $0.98 | $3K | Direct | Apr 3, 2019 (2d) |
| Jul 25, 2017 | RGLS | ↑ Buy | 54,945 | $0.91 | $50K | Direct | Jul 25, 2017 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LENZ insiders
Open-market trades in the last 12 months
About Daniel R. Chevallard's insider trades
Daniel R. Chevallard is Chief Financial Officer at LENZ Therapeutics (LENZ). Since Jul 25, 2017, Daniel has reported 3 open-market purchases worth $150K and 13 sales worth $120K on SEC Form 4. In the last 12 months: 1 buy ($50K).
1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (13 filings), option exercises (12 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LENZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.